Skip to Main Content

Advertisement

Skip Nav Destination

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Blood Adv (2023) 7 (14): 3749–3759.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement